Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 27 Oct 2022 07:00 CEST |
ARGENX SE | argenx Reports Third Quarter 2022 Financial Results and Provides Business Update | 20103010 Biotechnology | Other subject |
| 27 Oct 2022 06:59 CEST |
BELYSSE GROUP NV | Belysse Group nv Q3 2022 Results | 40202015 Household Furnishings | Other subject |
| 26 Oct 2022 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
| 26 Oct 2022 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
| 26 Oct 2022 17:43 CEST |
CRESCENT | GEREGLEMENTEERDE INFORMATIE - Crescent bevestigt benoeming van KPMG als commissaris | 15101010 Telecommunications Equipment | Other subject |
| 26 Oct 2022 17:41 CEST |
CRESCENT | REGULATED INFORMATION - Crescent confirms appointment of KPMG as auditor | 15101010 Telecommunications Equipment | Other subject |
| 26 Oct 2022 08:15 CEST |
AGEAS | Adverse financial markets in China and the strong impact of inflation in the UK and Türkiye affect Ageas’s Q3 2022 net result. Dividend commitment maintained. | 30301010 Life Insurance | Other financial transaction |
| 26 Oct 2022 08:15 CEST |
AGEAS | Marchés financiers défavorables en Chine et l’impact important de l’inflation au Royaume-Uni et en Turquie affectent le résultat net d'Ageas du 3ème trimestre 2022. L’engagement de dividende maintenu. | 30301010 Life Insurance | Other financial transaction |
| 26 Oct 2022 08:15 CEST |
AGEAS | Ongunstige financiële markten in China en de sterke impact van inflatie in het VK en Turkije beïnvloeden nettoresultaat van Ageas voor het derde kwartaal van 2022. Dividendtoezegging gehandhaafd. | 30301010 Life Insurance | Other financial transaction |
| 26 Oct 2022 07:00 CEST |
MELEXIS | Melexis Q3 2022 résultats – Chiffre d'affaires de 219.8 millions d'euros au troisième trimestre | 10102010 Semiconductors | Corporate life |
| 26 Oct 2022 07:00 CEST |
MELEXIS | Melexis Q3 2022 resultaten – Omzet van 219.8 miljoen EUR in het derde kwartaal | 10102010 Semiconductors | Corporate life |
| 26 Oct 2022 07:00 CEST |
MELEXIS | Melexis Q3 2022 results – Third quarter sales of 219.8 million EUR | 10102010 Semiconductors | Corporate life |
| 25 Oct 2022 18:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 september 2022 | 35102045 Retail REITs | New |
| 25 Oct 2022 18:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 September 2022 | 35102045 Retail REITs | New |
| 25 Oct 2022 18:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 septembre 2022 | 35102045 Retail REITs | New |
| 25 Oct 2022 17:46 CEST |
BALTA GROUP | Transparantieverklaring UBS GROUP AG | 40202015 Household Furnishings | Other subject |
| 25 Oct 2022 17:45 CEST |
BALTA GROUP | Transparency Notification UBS GROUP AG | 40202015 Household Furnishings | Other subject |
| 25 Oct 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 17/10/2022 tot 21/10/2022 | 30202010 Asset Managers and Custodians | Other subject |
| 25 Oct 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 17/10/2022 to 21/10/2022 | 30202010 Asset Managers and Custodians | Other subject |
| 25 Oct 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 17/10/2022 au 21/10/2022 | 30202010 Asset Managers and Custodians | Other subject |
| 25 Oct 2022 08:00 CEST |
BEFIMMO | Befimmo SA: Réouverture de l’Offre sous la forme d’un squeeze-out simplifié | 35102030 Office REITs | Takeover bids |
| 25 Oct 2022 08:00 CEST |
BEFIMMO | Befimmo NV: Heropening van het Bod als vereenvoudigde squeeze-out | 35102030 Office REITs | Takeover bids |
| 25 Oct 2022 08:00 CEST |
BEFIMMO | Befimmo SA: Reopening of the Offer as a simplified squeeze-out | 35102030 Office REITs | Takeover bids |
| 25 Oct 2022 07:00 CEST |
BONE THERAPEUTICS | Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation of Medsenic valued at EUR 40 million | 20103010 Biotechnology | Mergers, Acquiqitions, Transferts |
| 25 Oct 2022 07:00 CEST |
BONE THERAPEUTICS | Bone Therapeutics entame une nouvelle histoire sur Euronext et change de nom pour devenir BioSenic, suite à l'acquisition d'une participation majoritaire à hauteur de 40 M€ dans Medsenic | 20103010 Biotechnology | Mergers, Acquiqitions, Transferts |
| 25 Oct 2022 05:47 CEST |
BPOST | CEO ad interim | 50206040 Delivery Services | General meeting / Board Meeting |
| 25 Oct 2022 05:46 CEST |
BPOST | CEO ad interim | 50206040 Delivery Services | General meeting / Board Meeting |
| 25 Oct 2022 05:45 CEST |
BPOST | CEO ad interim | 50206040 Delivery Services | General meeting / Board Meeting |
| 24 Oct 2022 22:30 CEST |
NYXOAH SA | Nyxoah Annonce un Changement au Sein de son Conseil d’Administration | 20102010 Medical Equipment | Other subject |
| 24 Oct 2022 22:30 CEST |
NYXOAH SA | Nyxoah Announces Change to Board of Directors | 20102010 Medical Equipment | Other subject |
| 24 Oct 2022 18:06 CEST |
GBL | GBL - Transacties op GBL-aandelen 24-10-2022 | 30202000 Diversified Financial Services | Other financial transaction |
| 24 Oct 2022 18:05 CEST |
GBL | GBL - Transactions sur actions propres 24-10-2022 | 30202000 Diversified Financial Services | Other financial transaction |
| 24 Oct 2022 18:04 CEST |
GBL | GBL - Transactions on GBL shares 24-10-2022 | 30202000 Diversified Financial Services | Other financial transaction |
| 24 Oct 2022 18:04 CEST |
VASTNED BELGIUM | Vastned Belgium: Tussentijdse verklaring van de Raad van Bestuur per 30 september 2022 | 35102045 Retail REITs | Corporate life |
| 24 Oct 2022 18:04 CEST |
VASTNED BELGIUM | Vastned Belgium: Interim statement from the Board of Directors as at 30 September 2022 | 35102045 Retail REITs | Corporate life |
| 24 Oct 2022 18:04 CEST |
VASTNED BELGIUM | Vastned Belgium : Déclaration intermediaire du conseil d'administration au 30 septembre 2022 | 35102045 Retail REITs | Corporate life |
| 24 Oct 2022 17:48 CEST |
BALTA GROUP | Belysse Group nv zal op Euronext genoteerd worden als BELYS | 40202015 Household Furnishings | Other subject |
| 24 Oct 2022 17:47 CEST |
BALTA GROUP | Belysse Group nv will be listed on Euronext as BELYS | 40202015 Household Furnishings | Other subject |
| 24 Oct 2022 17:40 CEST |
KBC ANCORA ord | Update on share repurchase program KBC Ancora until 21 October 2022 | 30101010 Banks | Other subject |
| 24 Oct 2022 17:40 CEST |
KBC ANCORA ord | Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 21 octobre 2022 | 30101010 Banks | Other subject |
| 24 Oct 2022 17:40 CEST |
KBC ANCORA ord | Update inkoopprogramma KBC Ancora tot 21 oktober 2022 | 30101010 Banks | Other subject |
| 24 Oct 2022 08:39 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 24 Oct 2022 08:37 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
| 24 Oct 2022 08:00 CEST |
EURONAV | Euronav contracts two new Suezmax vessels for 2024 delivery | 50206030 Marine Transportation | Other subject |
| 24 Oct 2022 08:00 CEST |
EURONAV | Euronav contracteert twee nieuwe Suezmax-schepen voor levering in 2024 | 50206030 Marine Transportation | Other subject |
| 24 Oct 2022 07:30 CEST |
SOLVAY | Solvay expects record third quarter results and raises full year guidance | 55201000 Chemicals: Diversified | Corporate life |
| 24 Oct 2022 07:30 CEST |
SOLVAY | Solvay s’attend à un troisième trimestre record et relève ses prévisions pour l'ensemble de l'année | 55201000 Chemicals: Diversified | Corporate life |
| 24 Oct 2022 07:30 CEST |
SOLVAY | Solvay verwacht recordresultaten in het derde kwartaal en verhoogt verwachtingen voor het hele jaar | 55201000 Chemicals: Diversified | Corporate life |
| 24 Oct 2022 07:22 CEST |
JENSEN-GROUP | Update: Inkoop eigen aandelen | 50204000 Machinery: Industrial | Other subject |
| 24 Oct 2022 07:20 CEST |
JENSEN-GROUP | Update: share buy back | 50204000 Machinery: Industrial | Other subject |